V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20195147 | 20152211 | 1.74 | 97 | Curative (C) | null | 2017-01-17 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | DOCETAXEL | 100739876 |
| 20195163 | 20152212 | 1.97 | 86.2 | Palliative (P) | 2019-03-28 | 2019-03-29 | Docetaxel | 02 | N | DOCETAXEL | 101762611 |
| 20195167 | 20152213 | 1.73 | 55.8 | Palliative (P) | 2018-08-11 | 2018-10-03 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100655080 |
| 20195170 | 20152214 | 1.66 | 76.55 | null | 2017-07-18 | 2017-08-04 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100056897 |
| 20195171 | 20152215 | 1.75 | 59 | 03 | 2018-04-09 | 2018-05-24 | Docetaxel | 02 | N | DOCETAXEL | 101851016 |
| 20195174 | 20152216 | 1.85 | 59.2 | Palliative (P) | null | 2019-02-25 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101022769 |
| 20195183 | 20152217 | 1.74 | 90.2 | null | 2018-12-27 | 2018-12-28 | Cetuximab + FOLFIRI cycle1 | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100089587 |
| 20195201 | 20152218 | 1.67 | 65.9 | Palliative (P) | 2016-10-21 | 2016-11-06 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100072311 |
| 20195208 | 20152219 | 1.66 | 102.2 | Palliative (P) | 2018-10-01 | 2018-10-18 | Docetaxel | 02 | N | DOCETAXEL | 101528235 |
| 20195210 | 20152220 | 1.66 | 74.95 | Palliative (P) | 2019-10-11 | 2019-10-27 | Docetaxel | 02 | N | DOCETAXEL | 101394346 |
| 20195211 | 20152221 | 1.5 | 97.6 | Palliative (P) | null | 2018-10-18 | Docetaxel | 02 | N | DOCETAXEL | 100134615 |
| 20195216 | 20152222 | 1.53 | 68.8 | Palliative (P) | 2017-02-14 | 2017-03-17 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | DOCETAXEL | 100349247 |
| 20195218 | 20152223 | 1.6 | 99.8 | null | 2017-11-29 | 2017-11-29 | Docetaxel | 02 | N | DOCETAXEL | 101527735 |
| 20195227 | 20152224 | 1.54 | 53.9 | Palliative (P) | 2020-02-12 | 2020-03-11 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 101469734 |
| 20195238 | 20152225 | 1.66 | 98 | Palliative (P) | 2019-08-18 | 2020-03-19 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | DOCETAXEL | 100877368 |
| 20195241 | 20152226 | 1.6 | 56.3 | Palliative (P) | 2019-08-06 | 2019-08-06 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100824760 |
| 20195254 | 20152227 | 1.63 | 103 | Palliative (P) | 2019-12-22 | 2019-12-23 | CETUXIMAB + IRINOTECAN + MDG | N | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100598219 |
| 20195258 | 20152228 | 1.88 | 110 | Palliative (P) | 2019-08-22 | 2019-08-29 | Cetuximab + FOLFIRI cycle1 | 02 | N | DOCETAXEL | 100478430 |
| 20195290 | 20152229 | 1.69 | 75.4 | Neo-adjuvant (N) | 2017-09-01 | 2017-09-22 | Docetaxel | 02 | N | DOCETAXEL | 100931447 |
| 20195293 | 20152230 | 1.7 | 53.7 | Palliative (P) | 2017-04-27 | 2017-04-27 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100961992 |
| 20195294 | 20152231 | 1.88 | 81.2 | Curative (C) | 2018-04-02 | 2018-04-03 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101027355 |
| 20195308 | 20152232 | 1.7 | 68.2 | Palliative (P) | 2019-01-14 | 2019-01-14 | Gemcitabine + Capecitabine | 01 | null | CAPECITABINE + GEMCITABINE | 100752980 |
| 20195314 | 20152233 | 1.54 | 97 | Palliative (P) | 2019-06-10 | 2019-06-17 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100339827 |
| 20195322 | 20152234 | 1.7 | 79.8 | Curative (C) | 2021-01-28 | 2021-02-14 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101037744 |
| 20195325 | 20152235 | 1.6 | 65.9 | null | 2022-03-14 | 2022-03-29 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100533701 |
| 20195326 | 20152236 | 1.8 | 76 | null | 2018-03-26 | 2018-04-02 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 101251662 |
| 20195327 | 20152237 | 1.7 | 62 | Palliative (P) | 2017-02-01 | 2017-02-02 | Cetuximab + FLUOROURACIL + IRINOTECAN | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101567909 |
| 20195329 | 20152238 | 1.75 | 89 | Palliative (P) | 2018-02-10 | 2018-02-23 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100665206 |
| 20195335 | 20152239 | 1.93 | 59.5 | Palliative (P) | 2017-08-14 | 2017-08-22 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100762920 |
| 20195339 | 20152240 | 1.56 | 51.3 | Palliative (P) | null | 2019-06-30 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100562007 |
| 20195340 | 20152241 | 1.78 | 50.7 | Palliative (P) | 2019-11-03 | 2019-11-22 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101184271 |
| 20195342 | 20152242 | 1.61 | 72 | null | 2017-07-06 | 2017-07-06 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100866510 |
| 20195351 | 20152243 | 1.83 | 58 | Palliative (P) | 2017-10-30 | 2017-11-07 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101092509 |
| 20195352 | 20152244 | 1.67 | 56.1 | Adjuvant (A) | 2019-12-22 | 2020-01-09 | Docetaxel | 02 | N | DOCETAXEL | 101016564 |
| 20195354 | 20152245 | 1.62 | 75.3 | Palliative (P) | null | 2018-06-19 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100634107 |
| 20195358 | 20152246 | 1.7 | 58.2 | Curative (C) | 2018-03-25 | 2018-08-30 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101836466 |
| 20195368 | 20152247 | 1.88 | 79.2 | Palliative (P) | 2017-07-09 | 2017-07-10 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100758774 |
| 20195370 | 20152248 | 1.77 | 54.4 | null | 2017-05-26 | 2017-06-07 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100586502 |
| 20195374 | 20152249 | 1.68 | 66 | Palliative (P) | 2018-10-08 | 2018-10-29 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101656018 |
| 20195384 | 20152250 | 1.54 | 79 | null | 2019-09-21 | 2019-09-23 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101123414 |
| 20195391 | 20152251 | 2 | 63 | null | 2018-03-30 | 2018-04-06 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100644141 |
| 20195403 | 20152252 | 1.63 | 91.6 | null | 2018-10-19 | 2018-10-28 | Docetaxel 75mg/m2 (21 day) | 99 | null | DOCETAXEL | 101437266 |
| 20195406 | 20152253 | 1.52 | 83.9 | Palliative (P) | 2019-03-06 | 2019-03-06 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CAPECITABINE + GEMCITABINE | 101189856 |
| 20195408 | 20152254 | 1.84 | 53.3 | Palliative (P) | null | 2018-08-26 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CAPECITABINE + GEMCITABINE | 101803143 |
| 20195409 | 20152255 | 1.68 | 71.25 | Palliative (P) | 2017-10-09 | 2018-03-01 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101234948 |
| 20195418 | 20152256 | 1.62 | 88 | Palliative (P) | 2016-08-21 | 2016-09-02 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101661064 |
| 20195419 | 20152257 | 1.9 | 66.5 | Palliative (P) | 2018-11-07 | 2018-11-21 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100331157 |
| 20195422 | 20152258 | 1.63 | 82 | Palliative (P) | 2018-09-02 | 2018-09-02 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100319484 |
| 20195425 | 20152259 | 1.77 | 79.6 | Palliative (P) | 2018-11-17 | 2019-01-12 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100279233 |
| 20195463 | 20152260 | 1.74 | 69.1 | Palliative (P) | 2018-02-09 | 2018-02-11 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CAPECITABINE + GEMCITABINE | 101284064 |